Skip to content

Can Yoga-Based Psychotherapy Help People Overcome Addiction? A Pilot Study

Development, Validation, and Feasibility of Yoga based Psychotherapy Program for Substance Use Disorders YPPS A Pilot Randomized Controlled Trial - YPP-S

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087213
Enrollment
40
Registered
2025-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F112- Opioid dependence

Interventions

Intervention1: Group A Conventional pharmacotherapy + psychosocial support + YPP-S : Participants will receive a psychotherapy program which has its theoratical basis in Yogic Philosophy. Control Int

Sponsors

NIMHANS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age Adults aged 18 to 60. 2.Diagnosis Individuals who have a diagnosed substance use disorder as per the Diagnostic and Statistical Manual of Mental Disorders or DSM-5. 3.Substance Opioids 4.Willingness to Participate Participants who are willing to engage in Yogic Psychotherapy as a treatment modality for their substance use disorder. 5.Capacity to Provide Informed Consent Participants who have the cognitive and legal capacity to provide informed consent for participating in the study. 6.Mental Health Assess participants mental health to determine if they have any severe comorbid psychiatric disorders that may require specialized treatment or exclude them from the study. 7.Stability Individuals who are medically stable and not in immediate crisis or require acute medical intervention. 8.Language People who speak and understand English or Hindi.

Exclusion criteria

Exclusion criteria: 1. Severe Physical Health Issues Individuals with severe physical health conditions that contraindicate participation in yoga practices 2. Severe Mental Health Issues Participants with severe comorbid psychiatric disorders that may interfere with the study objectives or require specialized treatment 3. Crisis or Acute Medical Need Individuals who are in crisis or require acute medical intervention as they may not be suitable for a research study 4. Those being treated with conventional structured psychotherapy 5. Those with a change in medications in the last 8 weeks or in whom the change would be required in the next 8 weeks

Design outcomes

Primary

MeasureTime frame
Substance Craving measured using the Substance Craving Scale Days of Abstinence measured by counting the number of abstinent daysTimepoint: outcome will be assessed/estimated at baseline and 8 weeks

Secondary

MeasureTime frame
Anxiety assessed using the Hamilton Anxiety Rating Scale (HAM-A) Depression assessed using the Hamilton Depression Rating Scale (HAM-D) Perceived Stress assessed using the Perceived Stress Scale (PSS) Quality of Life assessed using the WHO Quality of Life Scale (WHO-BREF) Guna Composition (personality traits) assessed using the Vedic Personality Inventory Timepoint: outcome will be assessed at baseline & 8 weeks

Countries

India

Contacts

Public ContactDr Rajesh Nair

Swami Vivekananda Yoga Anusandhana Samsthana

rajeshnair@svyasa.edu.in9632164777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026